Thermo Fisher Scientific Inc. today completed its previously announced acquisition of the Advanced Bioprocessing business from BD (Becton, Dickinson and Company – NYSE: BDX), a leading global medical technology company, for $477 million in cash, subject to post-closing adjustments. The business will be integrated into Thermo Fisher’s Life Sciences Solutions Segment.
October 25, 2018
· 2 min read